TY - JOUR
T1 - Role and regulation of cd1d in normal and pathological B cells
AU - Chaudhry, Mohammed S.
AU - Karadimitris, Anastasios
N1 - Publisher Copyright:
© 2014 by The American Association of Immunologists, Inc.
PY - 2014/11/15
Y1 - 2014/11/15
N2 - CD1d is a nonpolymorphic, MHC class I-like molecule that presents phospholipid and glycosphingolipid Ags to a subset of CD1d-restricted T cells called invariant NKT (iNKT) cells. This CD1d-iNKT cell axis regulates nearly all aspects of both the innate and adaptive immune responses. Expression of CD1d on B cells is suggestive of the ability of these cells to present Ag to, and form cognate interactions with, iNKT cells. In this article, we summarize key evidence regarding the role and regulation of CD1d in normal B cells and in humoral immunity. We then extend the discussion to B cell disorders, with emphasis on autoimmune disease, viral infection, and neoplastic transformation of B lineage cells, in which CD1d expression can be altered as a mechanism of immune evasion and can have both diagnostic and prognostic importance. Finally, we highlight current and future therapeutic strategies that aim to target the CD1d-iNKT cell axis in B cells.
AB - CD1d is a nonpolymorphic, MHC class I-like molecule that presents phospholipid and glycosphingolipid Ags to a subset of CD1d-restricted T cells called invariant NKT (iNKT) cells. This CD1d-iNKT cell axis regulates nearly all aspects of both the innate and adaptive immune responses. Expression of CD1d on B cells is suggestive of the ability of these cells to present Ag to, and form cognate interactions with, iNKT cells. In this article, we summarize key evidence regarding the role and regulation of CD1d in normal B cells and in humoral immunity. We then extend the discussion to B cell disorders, with emphasis on autoimmune disease, viral infection, and neoplastic transformation of B lineage cells, in which CD1d expression can be altered as a mechanism of immune evasion and can have both diagnostic and prognostic importance. Finally, we highlight current and future therapeutic strategies that aim to target the CD1d-iNKT cell axis in B cells.
UR - http://www.scopus.com/inward/record.url?scp=84910136441&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1401805
DO - 10.4049/jimmunol.1401805
M3 - Review article
C2 - 25381357
AN - SCOPUS:84910136441
SN - 0022-1767
VL - 193
SP - 4761
EP - 4768
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -